Nathan Keller

Prof. Keller is head of clinical microbiology and a consultant on infectious diseases at the pediatric hemato-oncology department at Sheba Medical Center, Ramat Gan. He heads Israel’s national center for meningococcal disease, and is a member of Israel’s advisory committee for vaccines and infectious diseases. He serves on Sheba Medical Center’s animal ethical committee, as vice chairman of the hospital’s ethical review board, and as a member of Sheba’s formulary committee. He previously served as president of the Israeli Society for Infectious Diseases.

Prof. Keller is a member of the scientific advisory board at Pfizer Israel, MSD Israel, and Astella Israel. He is a scientific advisor to several Israeli biomed startups, including Pocared, Contipi, Elphitech, Eos, and other companies involved in developing microbiological diagnostics. Additionally, he is chairman of the advisory board at Anjon, USA, and a member of the advisory board at Safeguard Biosystems, USA

Having published over 147 manuscripts in peer-reviewed scientific journals, Prof. Keller’s main interests are diagnosis of infectious diseases, epidemiology of infectious diseases, epidemiology of antibiotic resistance, meningococcal disease, and fungal infections within pediatric hemato-oncology.

Prof. Keller is a graduate of Hadassah Medical School at the Hebrew University, Jerusalem, with a Ph.D in medical microbiology from the Royal University in Utrecht, and an MBA from Kellogg School of Management.